Decoding tumor–stroma interactions: from molecular crosstalk to therapeutic targets
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.70108 ↗Kurz gefasst
Editorial in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Isabel Fabregat. Beteiligte Einrichtung: TGF-β and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL) and CIBEREHD, L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Neoplasms, Stromal Cells, Tumor Microenvironment. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With this “In the Limelight: Tumor‐Stroma Interactions” special issue, FEBS Open Bio aims to highlight the relevance of the tumor stroma cells, and their interactions with the tumor cells, in the progression of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- TGF-β and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL) and CIBEREHD, L'Hospitalet de Llobregat, Barcelona, Spain.
Zitieren
APA
Fabregat, I. (2025). Decoding tumor–stroma interactions: from molecular crosstalk to therapeutic targets. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70108
Vancouver
Fabregat I. Decoding tumor–stroma interactions: from molecular crosstalk to therapeutic targets. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70108
BibTeX
@article{Fabregat2025,
author = {Fabregat, Isabel},
title = {Decoding tumor–stroma interactions: from molecular crosstalk to therapeutic targets},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.70108}
}
EUVIMED